Description
| Product Name | CAT.No | Size |
| Anti-Hbe | HBEABC20 | 20T |
| Anti-Hbe | HBEABC40 | 40T |
Product Description
The Biorex Diagnostics HBeAb One Step Rapid Test Device is a rapid, instrument-free immunochromatographic assay designed for the qualitative detection of Hepatitis B e Antibody (HBeAb) in human serum or plasma. This reliable test provides healthcare professionals with fast and accurate results to support clinical decision-making, blood donor screening, and patient monitoring in hospitals, clinical laboratories, and public health programmes. By identifying HBeAb, the assay helps determine the immune response and viral replication status in individuals with Hepatitis B virus (HBV) infection.
Key Features
- Rapid one-step immunoassay – qualitative results within minutes for timely clinical decisions
- Versatile sample compatibility – works with both serum and plasma, requiring minimal sample volume
- High sensitivity and specificity – accurately detects HBeAb-positive samples with minimal risk of false results
- Instrument-free operation – ideal for point-of-care testing, field studies, and routine laboratory use
- Ready-to-use format – minimal preparation, straightforward interpretation, and reduced risk of handling errors
Benefits
Routine use of the HBeAb Rapid Test Device enables early identification of Hepatitis B e Antibody, which is crucial for assessing the phase of HBV infection and monitoring antiviral therapy effectiveness. By providing rapid and accurate results, the assay supports blood transfusion safety, vaccination follow-up, and patient management. Its user-friendly, instrument-free design allows seamless integration into diverse clinical workflows, from busy hospital laboratories to remote healthcare settings.
The test’s high sensitivity and specificity enhance confidence in patient care and public health decision-making. Clinical laboratories benefit from reduced turnaround time, streamlined procedures, and improved workflow efficiency. Additionally, the HBeAb Rapid Test Device is a cost-effective solution for epidemiological surveys, routine monitoring programs, and diagnostic support in both endemic and low-prevalence areas.
Backed by Biorex Diagnostics’ expertise in in vitro diagnostics, this rapid test ensures reliable performance, ease of use, and dependable results, empowering healthcare professionals to make informed decisions and improve outcomes for patients affected by Hepatitis B.
Contact Us for more information.